Ontology highlight
ABSTRACT: Background
In China mainland, most Mycoplasma pneumoniae related studies are carried out in Beijing and Shanghai, while rare studies are performed in the other regions. In this study, we analyzed the molecular biology characteristics and antimicrobial susceptibility of clinical isolates of M. pneumoniae from 5 regions between January 2017 and December 2018.Methods
Genotyping was performed to 154?M. pneumoniae isolates from 5 cities using PCR and multiple-locus variable-number tandem repeat analysis (MLVA) method. Antimicrobial susceptibility test was performed to all the isolates against 4 antibiotics. Sequencing was performed to the amplification products of the 23S rRNA drug resistant gene.Results
Genotype I was detected in 118?M. pneumoniae isolates (76.6%), and genotype II was identified in 36 isolates (23.4%). The majority (92.2%) of the MLVA genotypes were 4-5-7-2 and 3-5-6-2, which represented the genotype I and II, respectively. The total macrolide (ML) resistance rate was 79.7%. The minimum inhibitory concentration (MIC) of the erythromycin was in a range of 128-?>?256??g/ml, while that for the azithromycin was 2-32??g/ml. There were mutations in the 23S rRNA in each ML resistance isolate. Jilin city showed the highest prevalence of genotype I (100%) and ML resistance rate (100%), while Jinan showed the lowest prevalence of genotype I (45.5%) and ML resistance rate (54.5%).Conclusions
A large variance was identified in the M. pneumoniae genotype and ML resistance among the 5 cities. The proportion of M. pneumoniae with a genotype II genotype (3-5-6-2) showed an increased trend.
SUBMITTER: Zhao F
PROVIDER: S-EPMC6708159 | biostudies-literature | 2019
REPOSITORIES: biostudies-literature
Zhao Fei F Li Jing J Liu Jinrong J Guan Xuemei X Gong Jie J Liu Liyong L He Lihua L Meng Fanliang F Zhang Jianzhong J
Antimicrobial resistance and infection control 20190823
<h4>Background</h4>In China mainland, most <i>Mycoplasma pneumoniae</i> related studies are carried out in Beijing and Shanghai, while rare studies are performed in the other regions. In this study, we analyzed the molecular biology characteristics and antimicrobial susceptibility of clinical isolates of <i>M. pneumoniae</i> from 5 regions between January 2017 and December 2018.<h4>Methods</h4>Genotyping was performed to 154 <i>M. pneumoniae</i> isolates from 5 cities using PCR and multiple-locu ...[more]